Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.Peter Kurtzhals(Novo Nordisk (Denmark)), Thomas Trüb(Novo Nordisk (Denmark))DiabetesJune 1, 200010.2337/diabetes.49.6.999Cited by 741SaveCiteExport RISWatch citationsRelated PapersStructure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor|Cell|1996|320